Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Aims: Obesity is a significant problem for patients taking atypical antipsychotics. There were two aims of our study. The first aim was to compare the prevalence of overweight and obesity between children and adolescents with autism spectrum disorder (ASD) treated with risperidone with the general p...

Full description

Bibliographic Details
Main Authors: Natchaya Vanwong, Nattawat Ngamsamut, Nopphadol Nuntamool, Yaowaluck Hongkaew, Rattanaporn Sukprasong, Apichaya Puangpetch, Penkhae Limsila, Chonlaphat Sukasem
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
obesity
children and adolescents
autism spectrum disorder
risperidone
ABCB1
HTR2C
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.565074/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.565074/full

Similar Items